Abstract
BackgroundPreventing work disability is an important treatment goal for people with rheumatic diseases. New treatment modalities with introduction of bDMARDs have led to better control of disease activity, symptoms and...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
